Risk Factors for Sub Mucosal Fibrosis During Achalasia Cardia: A Prospective Study
1 other identifier
observational
339
1 country
2
Brief Summary
Classification for Stasis Esophagitis: Grade I Grade II Grade III Vascular pattern Obscured Obscured Obscured Mucosal thickening No Yes Yes Ulceration No Yes Yes Nodularity No No Yes
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2021
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 14, 2021
CompletedFirst Submitted
Initial submission to the registry
February 4, 2025
CompletedFirst Posted
Study publicly available on registry
February 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2025
CompletedFebruary 11, 2025
February 1, 2024
3.5 years
February 4, 2025
February 7, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
The primary aim of the study is to evaluate the predictors for Sub mucosal fibrosis in cases with achalasia cardia.
sub mucosal fibres determination in different muscles of esophagus
100 minutes
Secondary Outcomes (1)
: To improve the technical outcomes of per oral endoscopy myotomy
100 minutes
Eligibility Criteria
339 subjects
You may qualify if:
- Patients (between 18 to 75 years of age) who underwent POEM for achalasia or other esophageal motility disorders.
- Had a diagnosis of esophageal achalasia confirmed by High Resolution Manometry, barium esophagogram.
You may not qualify if:
- Patients who underwent treatment other than achalasia
- Lost to follow up patients.
- Incomplete clinical record patients
- Patients not willing to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Asian institute of Gastroenterology/AIG Hospitals
Hyderabad, Telangana, 500079, India
Asian Institute of Gastroenterology /Aig Hospitals
Hyderabad, Telangana, 500082, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zaheer Nabi Dr Mohammed, MBBS MD
AIG Hospitals
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
February 4, 2025
First Posted
February 7, 2025
Study Start
August 14, 2021
Primary Completion
February 20, 2025
Study Completion
April 20, 2025
Last Updated
February 11, 2025
Record last verified: 2024-02